Moore Capital Management, LP Reata Pharmaceuticals Inc Transaction History

Moore Capital Management, LP

  • $4.85 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$79.22 - $105.37 $3.83 Million - $5.09 Million
-48,301 Reduced 82.85%
10,000 $1.02 Million
Q1 2023

May 15, 2023
BUY
$30.85 - $93.17 $1.8 Million - $5.43 Million
58,301 New
58,301 $5.3 Million
Q4 2018

Feb 14, 2019
SELL
$48.76 - $76.44 $731,400 - $1.15 Million
-15,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$35.64 - $92.06 $534,600 - $1.38 Million
15,000 New
15,000 $1.23 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email